Theranostics 2022; 12(14):6155-6156. doi:10.7150/thno.77186 This issue

Erratum

Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum

Xun Sun1,2, Kexin Li1,2, Rongrong Zha1,2, Shengzhi Liu2, Yao Fan1,2, Di Wu1,2, Misato Hase2,3, Uma K. Aryal4, Chien-Chi Lin2,5, Bai-Yan Li1 Corresponding address, Hiroki Yokota1,2,5,6 Corresponding address

1. Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
2. Department of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA.
3. Graduate School of Engineering, Mie University, Mie 514, Japan.
4. Department of Comparative Pathobiology, Purdue University, West Lafayette, IN 47907, USA.
5. Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
6. Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Sun X, Li K, Zha R, Liu S, Fan Y, Wu D, Hase M, Aryal UK, Lin CC, Li BY, Yokota H. Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum. Theranostics 2022; 12(14):6155-6156. doi:10.7150/thno.77186. Available from https://www.thno.org/v12p6155.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 5143

 

The authors regret that the original version of our paper, unfortunately, contained an incorrect picture in Figure 8B, where the images for the Calr case were mistakenly used for the Ppib case. The correct version of Figure 8B is shown below.

The correction made in this erratum does not affect the original data and conclusions. The authors apologize for any inconvenience that the errors may have caused.

 Figure 8 

Effects of Calr and Ppib on 4T1.2 mammary tumor cells. The double asterisk indicates p < 0.01. CN = control, and CM = conditioned medium. (A-B) Reduction in transwell invasion and EdU-based proliferation by recombinant Calr and Ppib proteins. (C) Reduction in Lrp5, MMP9, Runx2 and Snail by recombinant Calr and Ppib proteins. (D) Overexpression of Calr and Ppib in MSCs. (E-F) Reduction in Transwell invasion and EdU-based proliferation of 4T1.2 cells in response to Calr- and Ppib-overexpressing MSC CM. (G) Downregulation of Lrp5, MMP9, Runx2 and Snail in 4T1.2 cells in response to Calr- and Ppib-overexpressing MSC CM. (H) Upregulation of p53 in Calr- and Ppib-overexpressing MSC CM. (I) Elevation of phosphorylated eIF2a in 4T1.2 cells in response to Calr and Ppib recombinant proteins.

Theranostics Image

(View in new window)

Author contact

Corresponding address Corresponding authors: Hiroki Yokota, PhD, Department of Biomedical Engineering, Indiana U. Purdue U. Indianapolis, 723 West Michigan Street, SL220, Indianapolis, IN 46202 USA. Phone: 317-278-5177, Fax: 317-278-2455, E-mail: hyokotaedu; Bai-Yan Li, MD/PhD, Department of Pharmacology, School of Pharmacy, Harbin Medical University, #157 Baojian Road, Harbin 150081, China. Phone/Fax: +86 451-8667-134, E-mail: libyhrbmu.edu.cn.


Published 2022-8-18